Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest tren...
The new drug application included data from the Phase III eXalt3 study, publishe...
Originally operating as a subsidiary under BeiGene, Pi Health has become an inde...
Amidst the many BTK inhibitors, Breyanzi will be the first and only CAR-T cell t...
The committee ultimately backed the benefits of imetelstat based on data from th...
Research puts the spotlight on potential financial conflicts of interest (COI) a...
President Biden requests for the 2025 budget are potentially his last chance to ...
For-profit health system Steward Health Care's Massachusetts hospitals are teete...
In the last year, an estimated 11% of high school seniors have used Delta 8 THC,...
Researchers at the University of California, Los Angeles, have built a soft, adh...
Acadia Pharmaceuticals disclosed that Nuplazid failed to improve the social and ...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Pediatrician Paul Law fights measles in the Democratic Republic of Congo. He’s n...
The FDA is expected to approve the first medicine developed specifically to trea...
BIO severs ties with WuXi in response to increasing U.S. government scrutiny of ...
A now-former nurse convicted of accidentally killing a patient says, in addition...
